Molecular and Cellular Endocrinology
-
Publication Venue For
- Epigenetic regulation of male fate commitment from an initially bipotential system.. 468:19-30. 2018
- Purification and characterization of recombinant human mineralocorticoid receptor.. 302:81-85. 2009
- Steroidogenic factor-1 is a sphingolipid binding protein.. 265-266:174-178. 2007
- Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function.. 259:1-9. 2006
- Thyroid hormone action at the cellular, genomic and target gene levels.. 246:121-127. 2006
- Cell lines derived from pancreatic islets.. 228:121-128. 2004
- Nuclear receptor LXRalpha is involved in cAMP-mediated human renin gene expression.. 224:11-20. 2004
- AMH induces mesonephric cell migration in XX gonads.. 211:1-7. 2003
- WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells.. 208:61-75. 2003
- Cloning and expression of a novel, truncated, progesterone receptor.. 200:155-163. 2003
- Evaluation of the clinical efficacy of embryo cryopreservation.. 169:85-89. 2000
- Impact of different clinical variables on pregnancy outcome following embryo cryopreservation.. 169:73-77. 2000
- Steroidogenic factor 1 (SF-1) is essential for ovarian development and function.. 163:27-32. 2000
- Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells.. 160:67-73. 2000
- Identification of an enhancer element in the estrogen receptor upstream region: implications for regulation of ER transcription in breast cancer.. 158:25-36. 1999
- TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals.. 155:135-142. 1999
- Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.. 144:21-35. 1998
- Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol.. 142:203-214. 1998
- Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.. 141:53-64. 1998
- MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response.. 129:229-235. 1997
- Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome.. 127:221-228. 1997
- Glucose-dependent insulinotropic peptide (GIP) gene expression in the rat salivary gland.. 115:13-19. 1995
- Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells.. 112:61-68. 1995
- Region-specific anti-thyroid hormone receptor (TR) antibodies detect changes in TR structure due to ligand-binding and dimerization.. 97:93-99. 1993
- Tissue-specific expression of the rat androgen-binding protein/sex hormone-binding globulin gene in transgenic mice.. 96:69-73. 1993
- The androgen-binding protein gene is expressed in CD1 mouse testis.. 63:85-92. 1989
- Epidermal growth factor, vanadate, and 12-O-tetradecanoylphorbol-13-acetate inhibit growth and stimulate prostaglandin E2 production in A431 cells.. 57:87-92. 1988
- Differential secretion of proLHRH fragments in response to [K+], prostaglandin E2 and C kinase activation.. 55:95-100. 1988
- Increase in liver protein phosphatase-1 in spontaneously diabetic Chinese hamsters.. 50:115-122. 1987
- Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors.. 36:201-209. 1984
- The effect of plating density on granulosa cell growth and differentiation in vitro.. 34:201-213. 1984
- Calmodulin in endocrine cells and its multiple roles in hormone action.. 19:215-227. 1980
- Renal and hepatic lysosomal catabolism of luteinizing hormone.. 4:297-310. 1976
- The metabolism of luteinizing hormone. Plasma clearance, urinary excretion, and tissue uptake.. 3:21-36. 1975